Family Meeting Study for End Stage Renal Disease
- Conditions
- End-stage Renal Disease
- Interventions
- Behavioral: Family Consultation
- Registration Number
- NCT02504021
- Lead Sponsor
- Mark A. Lumley
- Brief Summary
A randomized clinical trial for patients with end stage renal disease in which a family consultation condition is compared against a treatment as usual control condition on the hospital readmissions after 1 month as the primary outcome variable.
- Detailed Description
Patients hospitalized at Henry For Hospital who have end stage renal disease will complete baseline questionnaires and be randomized into the experimental or control condition. Patients randomized into the experimental condition will have a single family consultation session before the patient is discharged. A trained, master's level therapist will conduct the family consultation, which will use education, motivational interviewing, and other techniques to help the family engage and support the patient's health needs. Patients in both the experimental and control conditions will complete follow up questionnaires 1 month after discharge. Investigators will conduct chart reviews of outcome data, including readmissions, at 1, 3, and 6 months post-discharge.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 120
- Hospitalized in inpatient Nephrology Unit at Henry Ford Hospital
- Has end-stage renal disease
- Willing and able to contact support person / family member about participating in the study
- Persistent Delirium
- Non-English speaking
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Family Consultation Condition Family Consultation The family consultation will be one, 1-hour session conducted by trained, master's level therapists. The goals of the meetings are: a) Review patient and family understanding of events that caused the hospital admission; b) increase family awareness of the level of cognitive impairment that the patient is experiencing; c) discuss ways the family can get involved and help the patient with their medication and dialysis adherence; d) use motivational interviewing techniques as needed. This will be provided in addition to the usual care that inpatients receive in this unit.
- Primary Outcome Measures
Name Time Method Early Hospital Readmissions - 1 Month 1 Month Were patients readmitted to the hospital within 1 month of their initial discharge?
- Secondary Outcome Measures
Name Time Method Change in Depression Baseline and 1-month follow-up Assessed using Patient Health Questionnaire 8
Change in Medication Adherence Baseline and 1-month follow-up Adherence to medication regimen. Items modified from Immunosuppressant Therapy Adherence Scale.
Change in Biological Measures of Health Baseline, 1, and 3 months Based on chart review, investigators will assess BUN, creatinine, substance use (tox screen), phosphorous, comorbidities, mortality
Change in Instrumental Social Support Baseline and 1-month follow-up Amount of involvement of support people in terms of disease management. Items modified from the Diabetes Social Support Questionnaire-Family.
Hospital Readmissions - 3 Months 3 Months Were patients readmitted to the hospital within 3 months of their initial discharge?
Change in Anxiety Baseline and 1-month follow-up Assessed using Generalized Anxiety Disorder Questionnaire-7
Trial Locations
- Locations (1)
Henry Ford Health System
🇺🇸Detroit, Michigan, United States